Top Abstract Purchase Related
Home
>
Node
>
Subnode

The prognostic value of thrombus precursor protein in the assessment of the probability for venous thrombosis recurrence after the completion of anticoagulatory therapy with warfarin

Kozlova, T.V.

Klinicheskaia Meditsina 84(12): 51-53

2006

ISSN/ISBN: 0023-2149
PMID: 17294885
Document Number: 597910
The article contains data on venous thrombosis (VT) recurrence rate in patients with the first episode of thrombus formation after the completion of one-year therapy with warfarin. The investigation included study of the prognostic value of intravascular coagulation marker (thrombus precursor protein --TPP) for the risk of venous retrombosis. The study showed that a high TPP level at the end of standard therapy course with warfarin in patients who had the first episode of spontaneous venous thrombosis is a significant indicator of a possible thrombosis recurrence during the nearest two tears after treatment with anticoagulants.

Document emailed within 1 workday
Secure & encrypted payments

Laurino, J.P.; Pelletier, T.E.; Eadry, R.; Kounavis, A. 1997: Thrombus Precursor Protein and the measurement of thrombosis in patients with acute chest pain syndrome Annals of Clinical and Laboratory Science 27(5): 338-345
Song, K.Soon.; Kim, H.Kyung.; Song, J.Woo. 2002: Measurement of thrombus precursor protein in septic patients with disseminated intravascular coagulation and liver disease Haematologica 87(10): 1062-1067
Balwierz, W.; Armata, J.; Tredowska, D.; Moryl-Bujakowska, A. 1988: Ovarian recurrence after the completion of therapy in two girls with acute lymphoblastic leukemia Pediatria Polska 63(12): 798-800
Schneider, J.; Hauser, R.; Hennies, H.H.; Korioth, J.; Steffens, G.; Wnendt, S. 1997: A novel chimaeric derivative of saruplase, rscu-PA-40 kDA/Hir, binds to thrombin and exerts thrombus-specific fibrinolysis in arterial and venous thrombosis in dogs Thrombosis and Haemostasis 77(3): 535-539
Gladson, C.L.; Scharrer, I.; Hach, V.; Beck, K.H.; Griffin, J.H. 1988: The frequency of type i heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis Thrombosis and Haemostasis 59(1): 18-22
Gallus, A.S.; Baker, R.I.; Chong, B.H.; Ockelford, P.A.; Street, A.M. 2000: Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis Medical journal of Australia 172(12): 600-605
Santo, S.D.; Tepper, O.M.; von Ballmoos, M.W.; Diehm, N.; Völzmann, J.; Baumgartner, I.; Kalka, C. 2009: Cell-based therapy facilitates venous thrombus resolution Thrombosis and Haemostasis 101(3): 460-464
Vucićević-Trobok, J.; Bogdanov, B.; Trifković, M.; Srdić, S. 2002: Treatment of pulmonary embolism and prevention of recurrence by placement of a vena cava filter in deep venous thrombosis: case report Medicinski Pregled 55(3-4): 149-152
Prountjos, P.; Bastounis, E.; Hadjinikolaou, L.; Felekuras, E.; Balas, P. 1991: Superficial venous thrombosis of the lower extremities co-existing with deep venous thrombosis. a phlebographic study on 57 cases International Angiology: a Journal of the International Union of Angiology 10(2): 63-65
Koopman, K.; Uyttenboogaart, M.; Vroomen, P.C.A.J.; van der Meer, J.; De Keyser, J.; Luijckx, G-Jan. 2009: Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years Thrombosis and haemostasis 102(4): 620-622
Michiels, J.J.; Bertina, R.M.; Broekmans, A.W.; Engesser, L.; van Vliet, H.H. 1987: A family with venous thrombosis and hereditary protein S deficiency Nederlands Tijdschrift Voor Geneeskunde 131(24): 1043-1047
Binaghi, G.; Prevosti, L.; Mortarino, G.; Giani, P.; Bruno, L.; Soldati, B.; Folli, G. 1970: Anticoagulatory therapy in myocardial infarct: case contribution Bollettino Della Societa Italiana di Cardiologia 15(1): 47-51
Jøssang, B.; Runde, I. 1992: Diagnostic value of C-reactive protein and D-dimer in deep venous thrombosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(9): 1153-1155
Domján, G.; Gruber, A.; Blaskó, G.; Petö, I.; Sas, G. 1985: Recurrent venous thrombosis in 2 Hungarian protein C-deficient families Orvosi Hetilap 126(52): 3191-3193
Laird, L.; Wille-Jørgensen, P. 2000: Risk assessment and novel therapeutic approaches: reducing the incidence and recurrence of deep vein thrombosis in the surgical patient. Conclusion Orthopedics 23(6 Suppl): S655-S656
Blanc, P.; Bories, P.; Donadio, D.; Parelon, G.; Rouanet, C.; Paleirac, G.; Michel, H. 1989: Ischemic colitis and recurrent venous thrombosis caused by familial protein S deficiency Gastroenterologie Clinique et Biologique 13(11): 945
Makanjuola, A.I.; Farombi, T.H.; Yaria, J.O.; Ogunjimi, L.O.; Ogunniyi, A. 2015: Cerebral Venous Thrombosis, Protein S Deficiency and Pregnancy Triad:A Case Report West African Journal of Medicine 34(3): 201-205
Bahloul, M.; Chaari, A.; Khlaf-Bouaziz, N.; Kallel, H.; Chaari, L.; Ben Hamida, C.; Chelly, H.; Rekik, N.; Bouaziz, M. 2005: Celiac disease, cerebral venous thrombosis and protein S deficiency, a fortuitous association? Journal des Maladies Vasculaires 30(4 Pt 1): 228-230
Krahenbuhl, B. 1988: The use of clinical assessment in the diagnosis of deep venous thrombosis. Practical application of Bayes theorem Journal des Maladies Vasculaires 13(1): 1-3
Mesters, R.M. 1999: Therapy of deep venous thrombosis Der Internist 40(10): 1098-1099